Commodore Capital Lp - Feb 7, 2025 SCHEDULE 13G Report for Nurix Therapeutics, Inc. Common Stock, par value $0.001 per share (NRIX)

Filing Manager
COMMODORE CAPITAL LP
Reporting Manager
COMMODORE CAPITAL LP
Security
Nurix Therapeutics, Inc. Common Stock, par value $0.001 per share
Symbol
NRIX
Shares outstanding
75.5M shares
Disclosed Ownership
3.85M shares
Ownership
5.1%
Form type
SCHEDULE 13G
Date filed
2/14/2025, 04:05 PM
Date of event
Feb 7, 2025
Next filing
Nov 14, 2025
SEC
View on sec.gov

Reporting Managers (2)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
COMMODORE CAPITAL LP 5.1% 3.85M 0 3.85M /s/ Michael Kramarz Michael Kramarz, Managing Partner
Commodore Capital Master LP 5.1% 3.85M 0 3.85M /s/ Michael Kramarz Michael Kramarz, Authorized Signatory